Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes. - Liu X; Liu Y; Liu H; Li H; Yang J; Hu P; Xiao X; Liu D (Frontiers in endocrinology, 2021)